Custom OEM Genetic Variation Analysis Systems Manufacturer & Factory

The Global Benchmark for High-Throughput Molecular Diagnostics and Precision Genomic Analysis Solutions.

🏢

Global Leadership in Molecular Diagnostics: Shenzhen BioX Medical

Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.

9,000+ Sqm Modern Facility
200+ Expert Employees
ISO Certified Quality Control
Global Supply Excellence

With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.

The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.

🚀

Genetic Variation Analysis Systems: Technical Roadmap & Future Vistas

The landscape of genomic analysis is shifting from basic detection to deep, integrated insights. Our technical roadmap focuses on the convergence of Digital PCR (dPCR), Next-Generation Sequencing (NGS), and Artificial Intelligence.

Ultra-Sensitivity dPCR

Transitioning beyond traditional qPCR to absolute quantification, enabling the detection of rare genetic mutations at concentrations below 0.1%.

AI-Driven Variant Calling

Integrating machine learning algorithms directly into the hardware to reduce bioinformatic bottlenecks, providing real-time SNP and Indel analysis.

Lab-on-a-Chip Miniaturization

Developing portable, cartridge-based systems that bring the power of a central lab to the point-of-care, ensuring rapid response in infectious disease monitoring.

Future vistas include the integration of Multi-omics data, where genetic variation analysis systems will cross-reference genomic data with proteomic and metabolomic profiles to provide a holistic view of human health.

Macro Industry Solutions: Bridging Science and Care

🧬

Oncology & Liquid Biopsy

Our systems facilitate non-invasive cancer monitoring through the detection of Circulating Tumor DNA (ctDNA), allowing for early intervention and personalized therapy adjustment.

💊

Pharmacogenomics (PGx)

Custom OEM solutions for high-throughput screening of genetic variations that affect drug metabolism (CYP450 variants), reducing adverse drug reactions globally.

🌍

Public Health Surveillance

Scalable platforms for national-level pathogen genomic surveillance, providing the backbone for pandemic preparedness and rapid variant tracking.

🏭

China Factory 4.0: Supply Chain Resilience & Efficiency

BioX Medical leverages the "Shenzhen Advantage"—the world's most concentrated ecosystem for medical electronics and biotechnology. Our Factory 4.0 initiatives ensure that we don't just manufacture; we optimize.

  • Smart Manufacturing: Automated assembly lines with real-time IoT monitoring reduce human error and ensure 99.9% consistency in optical alignment and thermal cycling precision.
  • Supply Chain Agility: By sourcing 85% of critical components within a 50km radius, we provide unmatched lead times, even during global supply disruptions.
  • Customization at Scale: Our modular production design allows for "Mass Customization," enabling OEM partners to modify hardware specifications without the typical "small-batch" cost penalties.
🛡️

Localization Support & Compliance Guarantee

Navigating the global regulatory landscape is the biggest hurdle in molecular diagnostics. BioX Medical provides a comprehensive compliance roadmap for our global partners:

Regulatory Alignment

Full support for CE-IVDR (EU), FDA 510(k) (USA), and NMPA (China) registrations, providing all necessary technical documentation and stability data.

Localization Services

Software UI/UX localization in 20+ languages and regional cloud server integration to comply with local data privacy laws (GDPR, HIPAA).

Technical Training

On-site and remote VR-assisted training for local engineering teams, ensuring the "BioX Quality" is maintained across all borders.

Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.

Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.

Global Enterprise Procurement & Partnerships

For global enterprises, the cost of ownership is as critical as the technology itself. Our procurement framework is designed for long-term scalability:

Volume Tier Pricing

Aggressive pricing structures for large-scale laboratory groups and national tenders, ensuring competitive ROI for diagnostic providers.

White-Label Options

Total brand integration, including custom chassis design, proprietary software branding, and unique reagent optimization.

LIMS Integration

Open API architecture allowing seamless integration with existing Laboratory Information Management Systems for automated data reporting.

Questions & Answers (FAQ)

What are the primary applications of BioX Genetic Variation Analysis Systems?
Our systems are used globally for oncology (liquid biopsy), inherited disease screening, pharmacogenomics, agricultural genomics (SNP genotyping), and infectious disease variant tracking (e.g., respiratory and blood-borne pathogens).
Do you offer custom reagent development alongside hardware OEM?
Yes, we provide an "Open Platform" approach where we can optimize our optical and thermal systems for your proprietary chemistry, or provide a complete turnkey solution with BioX-validated reagents.
What is the typical lead time for a custom OEM project?
Standard product customization (branding/software) typically takes 4-8 weeks. Full ODM projects involving new hardware architecture generally range from 6-12 months, depending on regulatory requirements.
How does BioX ensure data security in its diagnostic platforms?
Our systems feature localized data storage, encrypted transmission protocols, and multi-level user authentication. We assist partners in ensuring all workflows meet regional data protection standards like HIPAA or GDPR.

Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.